Latest News
March 1st, 2011
Announcing 510(k) Clearance of a New Microfluidic-based IVD Test System, the μTASWakoTM i30 Immunoanalyzer, and AFP-L3 and DCP Assays for Liver Cancer Risk Assessment.
Contact: Audrey Long at 877-714-1924
- Download μTASWako i30 Press Release for more detail
Oct. 2010
New! Quest Diagnostics now offers HCC panel test. This HCC panel test conveniently allows measurement of AFP-L3% and DCP with a single test code: 16222
- Visit "How to Order Tests" page for complete test codes
Contact Us
Clinical Diagnostic Reagents:
diagnostics@wakousa.com
HCC Biomarkers and
μTASWako® i30:
liver@wakousa.com
Phone: 877-714-1924
Certificates
ISO 13485:2003
Wako is a comprehensive manufacturer of Clinical Diagnostic reagents that are of the highest quality and extremely cost competitive. Our products are the result of over 75 years of dedication to the field of in vitro diagnostics.
General Info
Product List
Product Detail
HCC Biomarkers
FDA 510(k) Cleared
for HCC Risk Assessment
Wako's AFP-L3 and DCP (also known as PIVKA-II) tests are available through major reference labs.
To learn how HCC biomarkers can improve surveillance of HCC:
For Health care professionals
- HCC Biomarkers
- AFP-L3 Test
- DCP (PIVKA-II) Test
- Improved HCC Surveillance
- How to Order Tests
- Conference Information
- News Archive
- Resources
For Laboratories
For Patients
Meetings
DDW 2012
Digestive Disease Week
May 19-22, 2012
San Diego, CA
Booth TBD
Clinical Lab Expo 2012
AACC, American Association of Clinical Chemistry
July 15-19, 2012
Los Angeles, CA
Booth TBD
ACG 2012
American College of Gastroenterology
Oct 19-24, 2012
Las Vegas, NV
Booth TBD
TLM 2012
The Liver Meeting
Nov 1-5, 2012
Boston, MA
Booth TBD